The Board of Registration in Pharmacy held its regular meeting on November 6. The agenda included the following:
- New pharmacy labeling requirement (Shield Law 2.0)
- Pharmacy Advisory Committee meeting summary
- Recommendation for automated non-sterile compounding devices
MassHealth provided notice via All Provider Bulletin 412 to all providers using 340B drugs that it will stop paying for the high-cost drugs listed in this most recent bulletin, in addition to those outlined in All Provider Bulletin 390 and All Provider Bulletin 400. This follows M.G.L. c. 118E, § 13L, 130 CMR 405.000: Community Health Centers, 130 CMR 406.000: Pharmacy Services and 130 CMR 410.000: Outpatient Hospital Services.
MassHealth will implement these changes no sooner than May 4, 2026, through a follow-up All Provider Bulletin. MassHealth is inviting comments about these changes no later than December 3. See All Provider Bulletin 412 for details.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.